Identification of RNA partners of viral proteins in infected cells

RNA Biology

Volumn 10, Issue 6, 2013, Pages 943-956

  Komarova, Anastassia V ^a   Combredet, Chantal ^a   Sismeiro, Odile ^b   Dillies, Marie Agnès ^b   Jagla, Bernd ^b   David, Raul Yusef Sanchez ^a   Vabret, Nicolas ^a   Coppeé, Jean Yves ^b   Vidalain, Pierre Olivier ^a   Tangy, Fred́éric ^a  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Affinity purification; Measles virus; Next generation sequencing; Nucleocapsids; RNA protein interactions; Tagged proteins

Indexed keywords

PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; VIRUS NUCLEOPROTEIN; VIRUS PROTEIN; VIRUS RNA; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; NUCLEOPROTEIN; NUCLEOPROTEIN, MEASLES VIRUS; RECOMBINANT PROTEIN; RNA BINDING PROTEIN;

ARTICLE; CONTROLLED STUDY; GENOME; HIGH THROUGHPUT SEQUENCING; HUMAN; MEASLES VIRUS; MOLECULE; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REVERSE GENETICS; RNA VIRUS; VIRUS NUCLEOCAPSID; VIRUS RECOMBINANT; ANIMAL; CHLOROCEBUS AETHIOPS; GENETICS; HEK293 CELL LINE; ISOLATION AND PURIFICATION; METABOLISM; VERO CELL LINE;

MEASLES VIRUS; RNA VIRUSES;

ANIMALS; CERCOPITHECUS AETHIOPS; DEAD-BOX RNA HELICASES; HEK293 CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MEASLES VIRUS; NUCLEOPROTEINS; RECOMBINANT PROTEINS; RNA, VIRAL; RNA-BINDING PROTEINS; VERO CELLS; VIRAL PROTEINS;

EID: 84894582560     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.24453     Document Type: Article

References (39)

1. Panganiban AT, Mir MA. Bunyavirus N: eIF4F surrogate and cap-guardian. Cell Cycle 2009; 8:1332-7; PMID:19342890; http://dx.doi.org/10.4161/cc.8.9.8315.
2. Robb NC, Fodor E. The accumulation of influenza A virus segment 7 spliced mRNAs is regulated by the NS1 protein. J Gen Virol 2012; 93:113-8; PMID:21918006; http://dx.doi.org/10.1099/vir.0.035485-0.
3. Tanaka T, Kamitani W, Dediego ML, Enjuanes L, Matsuura Y. SARS coronavirus nsp1 facilitates an efficient propagation in cells through a specific translational shutoff of host mRNA. J Virol 2012; 86:11128-37; PMID:22855488; http://dx.doi.org/10.1128/JVI.01700-12.
4. Vende P, Piron M, Castagné N, Poncet D. Efficient translation of rotavirus mRNA requires simultaneous interaction of NSP3 with the eukaryotic translation initiation factor eIF4G and the mRNA 3′ end. J Virol 2000; 74:7064-71; PMID:10888646; http://dx.doi.org/10.1128/JVI.74.15.7064-7071.2000.
5. Hawkins RD, Hon GC, Ren B. Next-generation genomics: an integrative approach. Nat Rev Genet 2010; 11:476-86; PMID:20531367.
6. Baum A, Sachidanandam R, García-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci USA 2010; 107:16303-8; PMID:20805493; http://dx.doi.org/10.1073/pnas.1005077107.
7. Longhi S. Nucleocapsid structure and function. Curr Top Microbiol Immunol 2009; 329:103-28; PMID:19198564; http://dx.doi.org/10.1007/978-3-540-70523-9-6.
8. Gubbay O, Curran J, Kolakofsky D. Sendai virus genome synthesis and assembly are coupled: a possible mechanism to promote viral RNA polymerase processivity. J Gen Virol 2001; 82:2895-903; PMID:11714964.
9. Shingai M, Ebihara T, Begum NA, Kato A, Honma T, Matsumoto K, et al. Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus. J Immunol 2007; 179:6123-33; PMID:17947687.
10. Whistler T, Bellini WJ, Rota PA. Generation of defective interfering particles by two vaccine strains of measles virus. Virology 1996; 220:480-4; PMID:8661398; http://dx.doi.org/10.1006/viro.1996.0335.
11. Komarova AV, Combredet C, Meyniel-Schicklin L, Chapelle M, Caignard G, Camadro JM, et al. Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses. Mol Cell Proteomics 2011; 10:M110, 007443; PMID:21911578; http://dx.doi.org/10.1074/mcp.M110.007443.
12. Devaux P, Cattaneo R. Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function. J Virol 2004; 78:11632-40; PMID:15479804; http://dx.doi.org/10.1128/JVI.78.21.11632-11640.2004.
13. Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 2010; 11:R25; PMID:20196867; http://dx.doi.org/10.1186/gb-2010-11-3-r25.
14. Lazzarini RA, Keene JD, Schubert M. The origins of defective interfering particles of the negative-strand RNA viruses. Cell 1981; 26:145-54; PMID:7037195; http://dx.doi.org/10.1016/0092-8674(81)90298-1.
15. Marriott AC, Dimmock NJ. Defective interfering viruses and their potential as antiviral agents. Rev Med Virol 2010; 20:51-62; PMID:20041441; http://dx.doi.org/10.1002/rmv.641.
16. Strahle L, Garcin D, Kolakofsky D. Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology 2006; 351:101-11; PMID:16631220; http://dx.doi.org/10.1016/j.virol.2006.03.022.
17. Panda D, Dinh PX, Beura LK, Pattnaik AK. Induction of interferon and interferon signaling pathways by replication of defective interfering particle RNA in cells constitutively expressing vesicular stomatitis virus replication proteins. J Virol 2010; 84:4826-31; PMID:20181705; http://dx.doi.org/10.1128/ JVI.02701-09.
18. Marcus PI, Sekellick MJ. Defective interfering particles with covalently linked [+/-]RNA induce interferon. Nature 1977; 266:815-9; PMID:194158; http://dx.doi.org/10.1038/266815a0.
19. Yoneyama M, Fujita T. RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 2009; 227:54-65; PMID:19120475; http://dx.doi.org/10.1111/j.1600-065X.2008.00727.x.
20. Vidalain PO, Tangy F. Virus-host protein interactions in RNA viruses. Microbes Infect 2010; 12:1134-43; PMID:20832499; http://dx.doi.org/10.1016/j. micinf.2010.09.001.
21. Naji S, Ambrus G, Cimerman i P, Reyes JR, Johnson JR, Filbrandt R, et al. Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production. Mol Cell Proteomics 2012; 11:M111, 015313; PMID:22174317; http://dx.doi.org/10.1074/mcp.M111.015313.
22. Jäger S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, Clarke SC, et al. Global landscape of HIV-human protein complexes. Nature 2012; 481:365-70; PMID:22190034.
23. Radford AD, Chapman D, Dixon L, Chantrey J, Darby AC, Hall N. Application of next-generation sequencing technologies in virology. J Gen Virol 2012; 93:1853-68; PMID:22647373; http://dx.doi.org/10.1099/vir.0.043182-0.
24. Routh A, Domitrovic T, Johnson JE. Host RNAs, including transposons, are encapsidated by a eukaryotic single-stranded RNA virus. Proc Natl Acad Sci USA 2012; 109:1907-12; PMID:22308402; http://dx.doi.org/10.1073/pnas.1116168109.
25. Chi SW, Zang JB, Mele A, Darnell RB. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009; 460:479-86; PMID:19536157.
26. Rima BK, Duprex WP. The measles virus replication cycle. Curr Top Microbiol Immunol 2009; 329:77-102; PMID:19198563; http://dx.doi.org/10.1007/ 978-3-540-70523-9-5.
27. Calain P, Roux L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol 1993; 67:4822-30; PMID:8392616.
28. Calain P, Curran J, Kolakofsky D, Roux L. Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology 1992; 191:62-71; PMID:1329337; http://dx.doi.org/10.1016/0042- 6822(92)90166-M.
29. Baczko K, Billeter M, ter Meulen V. Purification and molecular weight determination of measles virus genomic RNA. J Gen Virol 1983; 64:1409-13; PMID:6854275; http://dx.doi.org/10.1099/0022-1317-64-6-1409.
30. Hall WW, Martin SJ. Purification and characterization of measles virus. J Gen Virol 1973; 19:175-88; PMID:4715320; http://dx.doi.org/10.1099/0022-1317- 19-2-175.
31. Combredet C, Labrousse V, Mollet L, Lorin C, Delebecque F, Hurtrel B, et al. A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice. J Virol 2003; 77:11546-54; PMID:14557640; http://dx.doi.org/10.1128/JVI.77.21.11546-11554.2003.
32. Giraudon P, Wild TF. Monoclonal antibodies against measles virus. J Gen Virol 1981; 54:325-32; PMID:7288410; http://dx.doi.org/10.1099/0022-1317-54-2- 325.
33. Takeuchi K, Kadota SI, Takeda M, Miyajima N, Nagata K. Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett 2003; 545:177-82; PMID:12804771; http://dx.doi.org/10.1016/S0014-5793(03)00528-3.
34. Jagla B, Wiswedel B, Coppée JY. Extending KNIME for next-generation sequencing data analysis. Bioinformatics 2011; 27:2907-9; PMID:21873641; http://dx.doi.org/10.1093/bioinformatics/btr478.
35. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009; 10:R25; PMID:19261174; http://dx.doi.org/10.1186/gb-2009-10-3-r25.
36. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al.; 1000 Genome Project Data Processing Subgroup. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25:2078-9; PMID:19505943; http://dx.doi.org/10. 1093/bioinformatics/btp352.
37. Team RDCR. A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2011.
38. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010; 26:139-40; PMID:19910308; http://dx.doi.org/10.1093/bioinformatics/ btp616.
39. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser A Stat Soc 1995; 57:289-300. virales